Novozymes A/S (NVZMY)

Market Cap	28.33B +6.1%
Revenue (ttm)	4.86B +19.3%
Net Income	641.79M +74.4%
EPS	2.24 +151.6%
Shares Out	n/a
PE Ratio	44.15
Forward PE	24.69
Dividend	0.56 (0.92%)
Ex-Dividend Date	Sep 2, 2025

Volume	1,462
Average Volume	46,755
Open	61.46
Previous Close	60.99
Day's Range	61.39 - 61.61
52-Week Range	53.95 - 75.99
Beta	0.78
RSI	39.00
Earnings Date	Feb 25, 2026

About Novozymes

Novozymes A/S produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company provides biosolutions for the food and beverage industry, such as dairy, baking, beverage, meat, plant-based, functional, and other foods, as well as protein solutions and early lie nutrition. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional lau...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 1925
• Employees: 10,582
• Stock Exchange: OTCMKTS
• Ticker Symbol: NVZMY

Financial Performance

In 2024, Novozymes's revenue was 3.83 billion, an increase of 59.58% compared to the previous year's 2.40 billion. Earnings were 305.80 million, a decrease of -24.66%.

Financial numbers in EUR